Surveillance of carbapenem-resistant pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-lactamases

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1660-1664

  Wolter, Daniel J ^a   Khalaf, Noha ^a,c   Robledo, Iraida E ^b   Vázquez, J Guillermo ^b   Santé, I Maria ^b   Aquino, Edna E ^b   Goering, Richard V ^a   Hanson, Nancy D ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^c HELWAN UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM; CEFTAZIDIME; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT; MALE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PORINS; PSEUDOMONAS AERUGINOSA;

EID: 65649116984     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01172-08     Document Type: Article

References (21)

1. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM.-30 beta-lactamases in New York City. Clin. Infect. Dis. 39:55-60. (Pubitemid 38879549)
2. Bratu, S., D. Landman, M. Alam, E. Tolentino, and J. Quale. 2005. Detec-tion of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother. 49:776-778. (Pubitemid 40175694)
3. Clinical and Laboratory Standards Institute. 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Deshpande, L. M., P. R. Rhomberg, H. S. Sader, and R. N. Jones. 2006. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers: report from the MYSTIC program (1999-2005). Diagn. Microbiol. Infect. Dis. 56:367-372.
5. Doern, G. V., R. N. Jones, M. A. Pfaller, M. Erwin, C. Ramirez-Rhonda, et al. 1998. Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. Diagn. Microbiol. Infect. Dis. 30:113-119.
6. Garza-Ramos, U., P. Tinoco, J. Silva-Sanchez, R. Morfln-Otero, E. Rodriguez-Noriega, G. Leon-Garnica, H. S. Sader, and R N. Jones. 2008. Metallo-beta-lactamase IMP-18 is located in a class 1 integran (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int. J. Antimicrob. Agents 31:78-80. (Pubitemid 350245737)
7. Giske, C. G., C. Boren, B. Wretlind, and G. Kronvall. 2005. Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA. Clin. Microbiol. Infect. 11:662-669. (Pubitemid 41051384)
8. Goering, R. V. 2004. Pulsed-fleld gel electrophoresis, p. 185-195. In D. H. Persing et al. (ed.), Molecular microbiology: diagnostic principles and prac-tice. ASM Press, Washington, DC.
9. Hanson, N. D., A. Hossain, L. Buck, E. S. Moland, and K. S. Thomson. 2006. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMF métallo-ß-lactamase, IMF-18. Antimicrob. Agents Che-mother. 50:2272-2273. (Pubitemid 43807565)
10. Köhler, T., M. Michea-Hamzehpour, S. F. Epp, and J. C. Pechere. 1999. Carbapenem activities against Pseudomonas aeruginosa: respective contribu-tions of OprD and efflux systems. Antimicrob. Agents Chemother. 43:424-427. (Pubitemid 29079192)
11. Lister, P. D. 2002. Chromosomally-encoded resistance mechanisms of Pseudomonas aeruginosa: therapeutic implications. Am. J. Fharmacogenom-ics 2:235-243. (Pubitemid 35429313)
12. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640. (Pubitemid 34165326)
13. Moland, E. S., N. D. Hanson, J. A. Black, A. Hossain, W. Song, and K. S. Thomson. 2006. Prevalence of newer ß-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J. Clin. Microbiol. 44:3318-3324. (Pubitemid 44413771)
14. Naas, T., G. Cuzon, M. V. Villegas, M. F. Lartigue, J. P. Quinn, and P. Nordmann. 2008. Genetic structures at the origin of acquisition of the ß-lactamase WORPC gene. Antimicrob. Agents Chemother. 52:1257-1263.
15. Rhomberg, P. R., L. M. Deshpande, J. T. Kirby, and R. N. Jones. 2007. Activity of meropenem as serine carbapenemases evolve in US medical centers: monitoring report from the MYSTIC program (2006). Diagn. Mi-crobiol. Infect. Dis. 59:415-432. (Pubitemid 46135866)
16. Robledo, I. E., E. S. Moland, E. A. Aquino, G. J. Vázquez, M. I. Santé, J. Bertrán, and N. D. Hanson. 2007. First report of a KPC-4 and CTX-M producing K. pneumoniae (Kp) isolated from Puerto Rico (PR), abstr. C2-1933. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL.
17. Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Flasmid-mediated, carbapenem-hydrolysing ß-lactamase, KPC-2, in Klebsiella pneu-moniae isolates. J. Antimicrob. Chemother. 51:711-714. (Pubitemid 36336168)
18. Vázquez, G. J., I. E. Robledo, A. Arroyo, E. Nadal, R. Rodríguez, and M. Bermůdez. 2003. A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affili-ated hospitals from Puerto Rico. P. R. Health Sei. J. 22:265-271.
19. Villegas, M. V., K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, and J. P. Quinn. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing ß-lactamase. Antimicrob. Agents Chemother. 51: 1553-1555. (Pubitemid 46586851)
20. Wolter, D. J., N. D. Hanson, and P. D. Lister. 2005. AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudo-monas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump. An-timicrob. Agents Chemother. 49:4763-4766. (Pubitemid 41552613)
21. Wolter, D. J., P. M. Kurpiel, N. Woodford, M. F. Palepou, R. V. Goering, and N. D. Hanson. 2009. phenotypic and enzymatic comparative analysis between the novel KPC variant, KPC-S, and its evolutionary variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother. 53:557-562.